Revolutionizing Immunity – Optimizing CAR-T for Breakthrough Therapies

SCIENCE

Our core platform technology utilizes empirical methodologies to identify optimized CAR, accelerating the development of advanced CAR-T cell therapies.

Through our novel approach, our CAR discovery process dynamically harmonizes scFv sequences via empirical evaluation, significantly enhancing the functional capabilities of T cells.

T-cells are a crucial part of the immune system, which require a certain level of signals to be activated. Identifying the precise level of stimulation that triggers T-cells to become fully and appropriately active is important in both immunology and therapeutic approaches like CAR-T cell therapy.

Our next-generation CAR constructs are engineered to achieve the optimal activation threshold for T-cells to ensure precise and efficient immune responses, demonstrating superior proliferative capacity, preventing antigen escape, and exhibiting exceptional reactivity against advanced tumor profiles.